Publications by authors named "Gary Doherty"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

38

Total Likes

0

Extended Reach

6,110

Social Features

5
S
Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC.
Tetsuya Mitsudomi, John V Heymach, Martin Reck, Janis M Taube, Shugeng Gao, Gary J Doherty

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and exposure-response analysis of durvalumab in patients with resectable stage II to IIIB (N2) NSCLC in the phase III AEGEAN study.
Xiaoying Zhao, Junjie Ding, Jiajia Zhao, Ling Zhang, Aburough Abegesah, Gary J Doherty

Br J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: The long-term effects of chemotherapy on normal blood cells.
Emily Mitchell, My H Pham, Anna Clay, Rashesh Sanghvi, Nicholas Williams, Gary J Doherty

Nat Genet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long-term effects of chemotherapy on normal blood cells.
Emily Mitchell, My H Pham, Anna Clay, Rashesh Sanghvi, Nicholas Williams, Gary J Doherty

Nat Genet· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential safety profiles of durvalumab monotherapy and durvalumab in combination with tremelimumab in adult patients with advanced cancers.
Claire Morgan, John Kurland, Mayur Patel, Cathy O'Brien, Pamela Concepcion, Gary J Doherty

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis.
Vinton W T Cheng, Richard Heywood, Rasheed Zakaria, Rebecca Burger, Kieran Zucker, Gary Doherty

Neuro Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning modeling of patient health signals informs long-term survival on immune checkpoint inhibitor therapy.
Gerald J Sun, Gustavo Arango-Argoty, Gary J Doherty, Damian E Bikiel, Dejan Pavlovic

iScience· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer.
Chris Abbosh, Darren Hodgson, Gary J Doherty, Davina Gale, James R M Black

Trends Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
John V Heymach, David Harpole, Tetsuya Mitsudomi, Janis M Taube, Gabriella Galffy, Gary J Doherty

N Engl J Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer.
Scott Haston, Estela Gonzalez-Gualda, Samir Morsli, Jianfeng Ge, Virinder Reen, Gary J Doherty

Cancer Cell· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising tissue acquisition and the molecular testing pathway for patients with non-small cell lung cancer: A UK expert consensus statement.
Neal Navani, Rachel Butler, Salma Ibrahimo, Anjali Verma, Matthew Evans, Gary J Doherty

Lung Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AACR Project GENIE: 100,000 Cases and Beyond.
Trevor J Pugh, Jonathan L Bell, Jeff P Bruce, Gary J Doherty, Matthew Galvin

Cancer Discov· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells.
Samir Morsli, Gary J Doherty, Daniel Muñoz-Espín

Mech Ageing Dev· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy.
Nicola A Thompson, Grant D Stewart, Sarah J Welsh, Gary J Doherty, Matthew J Robinson

BMC Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response of NOTCH1-Activated Tracheal Adenoid Cystic Carcinoma to the Gamma Secretase Inhibitor Nirogacestat.
Rosalind Kieran, Bruno H R de Paula, Michael Hubank, Allanah Barker, Anna L Paterson, Gary J Doherty

JCO Precis Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular senescence in cancer: from mechanisms to detection.
Hui-Ling Ou, Reuben Hoffmann, Cristina González-López, Gary J Doherty, James E Korkola

Mol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to BRAF and MEK1/2 inhibition in a young adult with BRAF V600E mutant epithelioid glioblastoma multiforme: A Case Report and Literature Review.
Ashwin Venkatesh, Amol Joshi, Kieren Allinson, Tilak Das, Thomas Santarius, Gary J Doherty

Curr Probl Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoids in glioblastoma multiforme-hype or hope?
Gary J Doherty, Bruno H R de Paula

Br J Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The care of older cancer patients in the United Kingdom.
Fabio Gomes, Anna Lewis, Rob Morris, Ruth Parks, Tania Kalsi, Gary J Doherty

Ecancermedicalscience· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking cancer clinical trials for COVID-19 and beyond.
Gary J Doherty, Mehmet Goksu, Bruno H R de Paula

Nat Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic.
Bruno H R de Paula, Indiara Araújo, Lívia Bandeira, Nathália M P B Barreto, Gary J Doherty

Lancet Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity.
Estela González-Gualda, Marta Pàez-Ribes, Beatriz Lozano-Torres, David Macias, Joseph R Wilson, Gary J Doherty

Aging Cell· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting senescent cells in translational medicine.
Marta Paez-Ribes, Estela González-Gualda, Gary J Doherty, Daniel Muñoz-Espín

EMBO Mol Med· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Treatment in the Genomic Era.
Gary J Doherty, Michele Petruzzelli, Emma Beddowes, Saif S Ahmad, Carlos Caldas

Annu Rev Biochem· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis